4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-25-007400
CHIEF EXECUTIVE OFFICER gave up 44,025 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2025-11-16 | Shares withheld for taxes | −44,025 | $4.83 | $212,641 | 6,436,800 | D |
Loading xslF345X05/ownership.xml…